This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Activity
  • Evaluation
  • Claim Credit
Optimizing Multiple Sclerosis Diagnosis and Treatment Across Phenotypes: Expert Direction on Applying the Latest Clinical Guidance and Evidence to Challenging

Optimizing Multiple Sclerosis Diagnosis and Treatment Across Phenotypes: Expert Direction on Applying the Latest Clinical Guidance and Evidence to Challenging

Format

Patient Case Study

Time to Complete

1 hour

Released

July 18, 2019

Expires

July 18, 2020
Add to Queue


Maximum Credits

1.00 / AMA PRA Category 1 Credit(s)TM

Accredited Provider


Jointly provided by the Postgraduate Institute for Medicine and Enquiring Minds, LLC.

Commercial Supporter

Supported by an independent educational grant provided by Genentech

Program Description

4 patient cases that enable clinicians to evaluate and integrate expert guidance when tailoring treatment plans:

  • Applying the updated 2017 McDonald criteria for more accurate diagnosis, early disease modifying
    therapy initiation, and prevention of misdiagnosis
  • MS phenotypes and implications for diagnosis and treatment
  • Treatment guidelines: updates and caveats to practice integration
  • Identifying and addressing common barriers to therapeutic optimization

Intended Audience

This activity is intended for physicians engaged in the care of patients with multiple sclerosis.

Educational Objectives

After completing this activity, the participant should be better able to:

  • Apply evidence-based strategies when diagnosing individuals with MS, monitoring disease progression, and assessing therapeutic response
  • Discuss the strengths and weakness of current best practices and emerging therapeutic options for treating MS across phenotypes
  • Individualize therapeutic decisions by integrating patient and clinical factors, such as MS phenotype, level of disease activity and prior treatment, with the latest evidence and guidance for MS diagnosis and management

Disclosure of Conflicts of Interest

The Postgraduate Institute for Medicine requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Faculty

Andrew J. Solomon, MD
Assistant Professor of Neurological Sciences
Division Chief, Multiple Sclerosis
Larner College of Medicine at The University of Vermont
Burlington, Vermont

Dr. Solomon receives consulting fees from EMD Serono and receives contracted Research fees from Biogen, Novartis, Actelion and Genentech.

Myla D. Goldman, MD
Associate Professor of Neurology
University of Virginia Health System School of Medicine
Director, James Q. Miller Multiple Sclerosis Center
Charlottesville, Virginia

Dr. Goldman receives consulting fees from Celgene, EMD Serono, Genzyme, Novartis, and Teva Pharmaceuticals.

Accredited Provider Disclosure

Planners and Managers

The PIM planners and managers have nothing to disclose. The Enquiring Minds, LLC planners and managers have nothing to disclose.

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement


In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Enquiring Minds, LLC. The Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation Statement

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM  .  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Fee Information

There is no fee for this educational activity.

Media

Internet

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Instructions

There are no fees for participating and receiving CME/CE credit for this activity. During the period July 18, 2019 through July 18, 2020, participants must read the learning objectives and faculty disclosures and successfully complete the activity evaluation. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

System Requirements
Windows: Internet Explorer 11, Microsoft Edge (latest version), Google Chrome (latest version), Firefox (latest version)
Mac: Safari (latest version), Google Chrome (latest version), Firefox (latest version)
Mobile: Safari in Apple iOS 10 or later, Google Chrome in Apple iOS 10 or later, Google Chrome in Android 4.4 or later

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue